PDLIM2 and acute myeloid leukemia: We additionally employed the Kaplan–Meier method to assess how PDLIM2 expression is related to prognosis in various cancer types, revealing its elevation to be significantly linked with adenoid cystic carcinoma (ACC; P = 0.008), BLCA (P = 0.038), acute myeloid leukemia (P < 0.001), and LUSC (P = 0.037) (Fig. 2b–e).